பிரதிநிதி பாப்யுலேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN FRANCISCO, March 15, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 – Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the primary endpoint of objective response rate (ORR), which might have introduced unmeasured bias and influence on the blinded independent central review (BIC ....

Hagens Berman , Metastatic Breast Cancer , Securities Class Action , Class Period , Drug Candidate , Representative Population , கென்ஸ் பெர்மன் , மெட்டாஸ்டேடிக் மார்பக புற்றுநோய் , பத்திரங்கள் வர்க்கம் நடவடிக்கை , வர்க்கம் காலம் , மருந்து வேட்பாளர் , பிரதிநிதி பாப்யுலேஶந் ,